Learn More
Medchemexpress LLC AST5902 trimesylate | 2929417-90-1 | 98.75% | 842.88 | 100 MG

Supplier: Medchemexpress LLC HY138627A100MG
AST5902 trimesylate is the principal metabolite of Alflutinib in vitro and in vivo. It exhibits antineoplastic activity, and Alflutinib is known as an EGFR inhibitor.
- Principal metabolite of Alflutinib
- Exhibits antineoplastic activity
- Targets EGFR
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.